The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
A review of anti-VEGF agents for proliferative diabetic retinopathy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Brown, D. M., Nguyen, Q. D., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Schlottmann, P. G., Rundle, A. C., Zhang, J., Rubio, R. G., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.02.034 · Cited by 830
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Preliminary Report on Effects of Photocoagulation Therapy
(1976) · American Journal of Ophthalmology · doi:10.1016/0002-9394(76)90292-0 · Cited by 723
Nishijima, K., Ng, Y.-S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S. J., Robinson, G. S., Adamis, A. P., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061237 · Cited by 707
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 640
Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis
Shibuya, M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.469 · Cited by 623
Saint-Geniez, M., Maharaj, A. S. R., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J., & D'Amore, P. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003554 · Cited by 616
Kalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O., Gravereaux, E., Pieczek, A., Iwaguro, H., Hayashi, S.-I., Isner, J. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1198 · Cited by 564
SPAIDE, R. F., & FISHER, Y. L. (2006) · Retina · doi:10.1097/00006982-200603000-00004 · Cited by 507
Wu, L., Martínez-Castellanos, M. A., Quiroz-Mercado, H., Arevalo, J. F., Berrocal, M. H., Farah, M. E., Maia, M., Roca, J. A., Rodriguez, F. J., & for the Pan American Collaborative Retina Group (PACORES) (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0660-z · Cited by 456
Arevalo, J. F., Maia, M., Flynn, H. W., Saravia, M., Avery, R. L., Wu, L., Farah, M. E., Pieramici, D. J., Berrocal, M. H., & Sanchez, J. G. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.127142 · Cited by 411
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Do, D. V., Nguyen, Q. D., Boyer, D., Schmidt-Erfurth, U., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Ruckert, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.010 · Cited by 385
REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
AVERY, R. L. (2006) · Retina · doi:10.1097/00006982-200603000-00016 · Cited by 342
Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., Young, P. P., Li, B., Sharpe, E. E., Maupin, A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5137fje · Cited by 324
Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration
D’Amico, D. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.027 · Cited by 260
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)
JORGE, R., COSTA, R. A., CALUCCI, D., CINTRA, L. P., & SCOTT, I. U. (2006) · Retina · doi:10.1097/01.iae.0000246884.76018.63 · Cited by 258
The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Do, D. V., Schmidt-Erfurth, U., Gonzalez, V. H., Gordon, C. M., Tolentino, M., Berliner, A. J., Vitti, R., Rückert, R., Sandbrink, R., Stein, D., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.018 · Cited by 253
Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.012 · Cited by 244
The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
Kuiper, E. J., Van Nieuwenhoven, F. A., de Smet, M. D., van Meurs, J. C., Tanck, M. W., Oliver, N., Klaassen, I., Van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002675 · Cited by 241
(1987) · International Ophthalmology Clinics · doi:10.1097/00004397-198702740-00004 · Cited by 210
Pars Plana Vitrectomy in the Early Treatment Diabetic Retinopathy Study
Flynn, H. W., Chew, E. Y., Simons, B. D., Barton, F. B., Remaley, N. A., & Ferris, F. L. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31779-8 · Cited by 202
Rizzo, S., Genovesi-Ebert, F., Di Bartolo, E., Vento, A., Miniaci, S., & Williams, G. (2008) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0774-y · Cited by 195
Maharaj, A. S. R., & D'Amore, P. A. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.03.004 · Cited by 195
CHEN, E., & PARK, C. H. (2006) · Retina · doi:10.1097/01.iae.0000225351.87205.69 · Cited by 193
Oshima, Y., Shima, C., Wakabayashi, T., Kusaka, S., Shiraga, F., Ohji, M., & Tano, Y. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.11.005 · Cited by 188
Ahmadieh, H., Shoeibi, N., Entezari, M., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.07.001 · Cited by 154
Smith, J. M., & STEEL, D. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008214.pub3 · Cited by 142
Shimura, M., Yasuda, K., Nakazawa, T., Kano, T., Ohta, S., & Tamai, M. (2003) · Ophthalmology · doi:10.1016/j.ophtha.2003.05.008 · Cited by 138
Singerman, L. J., Masonson, H., Patel, M., Adamis, A. P., Buggage, R. R., Cunningham, E. T., Goldbaum, M., Katz, B., & Guyer, D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.132597 · Cited by 132
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
Arévalo, J. F., Sánchez, J. G., Wu, L., Maia, M., Alezzandrini, A., Brito, M., Bonafonte, S., Lujan, S., Díaz-Llopis, M., Restrepo, N. A., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.016 · Cited by 130
Wang, X., Wang, G., & Wang, Y. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.007 · Cited by 128
Tonello, M., Costa, R. A., Almeida, F. P. P., Barbosa, J. C., Scott, I. U., & Jorge, R. (2007) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.01056.x · Cited by 125
Ladas, I. D., Karagiannis, D. A., ROUVAS, A. A., Kotsolis, A. I., LIOTSOU, A., & Vergados, I. A. (2009) · Retina · doi:10.1097/iae.0b013e31819a5f98 · Cited by 124
Mirshahi, A., Roohipoor, R., Lashay, A., Mohammadi, S.-F., Abdoallahi, A., & Faghihi, H. (2008) · European Journal of Ophthalmology · doi:10.1177/112067210801800215 · Cited by 123
Ahn, J., Woo, S. J., Chung, H., & Park, K. H. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.03.036 · Cited by 111
(2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2015 · Cited by 105
VANDER, J. F., Duker, J. S., Benson, W. E., Brown, G. C., McNamara, J. A., & Rosenstein, R. B. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32085-2 · Cited by 101
Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy
Jardeleza, M. S. R., & Miller, J. W. (2009) · Seminars in Ophthalmology · doi:10.1080/08820530902800330 · Cited by 93
BEVACIZUMAB PRETREATMENT IN VITRECTOMY WITH SILICONE OIL FOR SEVERE DIABETIC RETINOPATHY
Yeh, P., Yang, C., Lin, Y.-C., Chen, M., & Yang, C. (2009) · Retina · doi:10.1097/iae.0b013e3181a3b7ef · Cited by 88
Vascular Endothelial Cell Growth Factor-A
D'Amore, P. A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070385 · Cited by 84
El‐Asrar, A. M. A., Missotten, L., & Geboes, K. J. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.109876 · Cited by 71
Intravitreal injections: a review of the evidence for best practice
Fagan, X. J., & Al‐Qureshi, S. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12026 · Cited by 67
Self-citationIntravitreal Bevacizumab for Diabetic Retinopathy
Arévalo, J. F., & Garcia-Amaris, R. A. (2009) · Current Diabetes Reviews · doi:10.2174/157339909787314121 · Cited by 64
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
Arévalo, J. F., Sánchez, J. G., Lasave, A. F., Wu, L., Maia, M., Bonafonte, S., Brito, M., Alezzandrini, A., Restrepo, N. A., Berrocal, M. H., et al. (2011) · Journal of Ophthalmology · doi:10.1155/2011/584238 · Cited by 61
Intravitreal bevacizumab (Avastin®) in proliferative diabetic retinopathy
Minnella, A. M., Savastano, M. C., Ziccardi, L., Scupola, A., Sasso, P., Falsini, B., & Balestrazzi, E. (2007) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.01042.x · Cited by 61
Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication
Jalil, A., Fenerty, C., & Charles, S. (2007) · Eye · doi:10.1038/sj.eye.6703018 · Cited by 58
FRENKEL, R. E. P., Mani, L., Toler, A. R., & Frenkel, M. P. C. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.052 · Cited by 55
Mason, J. O., Yunker, J. J., Vail, R. S., & McGwin, G. (2008) · Retina · doi:10.1097/iae.0b013e31818356fb · Cited by 52
Lim, J. I., Spee, C. K., & Hinton, D. R. (2010) · Retina · doi:10.1097/iae.0b013e3181d6df09 · Cited by 47
The Role of Bevacizumab as First-line Therapy for Colon Cancer
Marshall, J. K. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.06.003 · Cited by 44
Anti-VEGF Therapy in Proliferative Diabetic Retinopathy
Abdallah, W., & Fawzi, A. A. (2009) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31819fd84a · Cited by 40
Thew, M. (2008) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2008.00295.x · Cited by 24
Smith, J. M., & STEEL, D. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008214.pub2 · Cited by 23
Systemic Adverse Events after Bevacizumab
Roth, D. B., King, A., Weiss, M., & Klein, D. B. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.02.011 · Cited by 21
Hussain, N., Ghanekar, Y., & Kaur, I. (2007) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.36480 · Cited by 20
Systemic effects of intravitreal vascular endothelial growth factor inhibitors
Bell, C. M., Bell, C. M., Campbell, E. D. L. P., & Gill, S. S. (2013) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32835f8bbe · Cited by 14
Cited by
Targeting angiogenesis in oncology, ophthalmology and beyond
Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 315
Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
Peng, Y., Tang, L., & Zhou, Y. (2017) · Ophthalmic Research · doi:10.1159/000479157 · Cited by 175
Bioactive lipids and pathological retinal angiogenesis
Elmasry, K., Ibrahim, A. S., Abdulmoneim, S., & Al‐Shabrawey, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14507 · Cited by 39
Shi, J., Lv, H., Tang, C., Li, Y., Huang, J., & Zhang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12112 · Cited by 34
Metadata
- Authors
- Osaadon, P., Fagan, X. J., Lifshitz, T., & Levy, J.
- Venue
- Eye
- Published
- 2014-02-14
- Volume
- 28
- Issue
- 5
- Pages
- 510-520
- ISSN
- 0078-5334 (ISSN-L)
- 0950-222X
- 1476-5454
- OpenAlex
- W2064268032
- Cited by
- 265
- References
- 65
- FWCI
- 15.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.